Simple jQuery Dropdowns
Please use this identifier to cite or link to this item: http://repository.li.mahidol.ac.th/dspace/handle/123456789/11496
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPreamrudee Poomthavornen_US
dc.contributor.authorRatchadaporn Suphasiten_US
dc.contributor.authorPat Mahachoklertwattanaen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-05-03T08:01:09Z-
dc.date.available2018-05-03T08:01:09Z-
dc.date.issued2011-08-01en_US
dc.identifier.citationGynecological Endocrinology. Vol.27, No.8 (2011), 524-528en_US
dc.identifier.issn14730766en_US
dc.identifier.issn09513590en_US
dc.identifier.other2-s2.0-79959931994en_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=79959931994&origin=inwarden_US
dc.identifier.urihttp://repository.li.mahidol.ac.th/dspace/handle/123456789/11496-
dc.description.abstractBackground.?Long-term outcome data of central precocious puberty (CPP) girls treated with gonadotropin-releasing hormone analogue (GnRHa) are conflicting. Aim.?To assess long-term outcome of girls with idiopathic CPP (iCPP) treated with GnRHa Methods.?We compared adult height (AH), body mass index (BMI) and time of menarche in GnRHa-treated (n = 47) and untreated (n = 11) girls with iCPP. Results.?There were no differences in age, bone age, height, weight and BMI z-scores, predicted adult height (PAH) at the time of diagnosis and target height between the two groups. Mean (SD) age of GnRHa-treated girls was 8.5 (1.0) years at the start of treatment. Mean (SD) AH of the treated group was greater [158.6 (5.2) vs. 154.8 (5.6) cm], p < 0.05. AH gain over pre-treatment PAH in the treated group was 4.7 cm. BMI z-score of treated girls was 1.26 (0.95) before the treatment initiated and returned to normal [0.16 (1.0)] at the time of AH reached. Menstruation occurred at 0.9 (0.5) years following GnRHa discontinuation with regular pattern. Conclusions.?Long-term GnRHa therapy has a modest beneficial effect on adult height gain in girls with iCPP. No detrimental effects on increasing BMI and hypothalamicpituitarygonadal axis reactivation are demonstrated. © 2010 Informa UK, Ltd.en_US
dc.rightsMahidol Universityen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=79959931994&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectMedicineen_US
dc.titleAdult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatmenten_US
dc.typeArticleen_US
dc.rights.holderSCOPUSen_US
dc.identifier.doi10.3109/09513590.2010.507289en_US
Appears in Collections:Scopus 2011-2015

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.